
On October 1, 2019, in Honeywell Int’l Inc. v. Arkema Inc., Appeals 2018-1151, -1153 (Fed. Cir. Oct. 1, 2019), the Federal Circuit held...
By Patrick Moon Comments are off
On October 1, 2019, in Honeywell Int’l Inc. v. Arkema Inc., Appeals 2018-1151, -1153 (Fed. Cir. Oct. 1, 2019), the Federal Circuit held...
Tagged with: Appeal, Federal Circuit, PGR, PTAB
ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:
By Anjali Jenna (AJ) Teigen Comments are off
On October 22, 2019, the USPTO published a Federal Register notice proposing changes to the rules of practice for inter partes review...
ShareEmail, Linked In, Twitter, Facebook, Google Plus
By Jennifer B. Maisel Comments are off
The Supreme Court of the United States issued a ruling today in Return Mail, Inc. v. Postal Service, 587 U.S. ___ (2019), holding that the...
Tagged with: AIA, Appeal, CBM, Federal Circuit, IPR, PGR, Supreme Court, USPTO
ShareEmail, Linked In, Twitter, Facebook, Google Plus
By Spencer J. Johnson Comments are off
On April 16, 2019, the Patent Trial and Appeal Board (“the PTAB” or “the Board”) designated three orders as precedential related to...
Tagged with: Federal Circuit, IPR, Patent, PGR, Precedential Decisions, PTAB
ShareEmail, Linked In, Twitter, Facebook, Google Plus
By Martin M. Zoltick and Michael H. Jones Comments are off
On October 11, 2018, the United States Patent and Trademark Office (USPTO) announced a change in the claim construction standard used for...
ShareEmail, Linked In, Twitter, Facebook, Google Plus
By Aydin H. Harston Comments are off
Since the Federal Circuit’s October 5, 2017 decision in Amgen Inc. v. Sanofi overruling the so-called “newly characterized antigen”...
Tagged with: Federal Circuit, Patent, PGR, USPTO
ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:
By Caitlin M. Wilmot Comments are off
On Friday, January 19, 2018, in a Federal Register notice, the USPTO identified four regulations that it is proposing to abolish. The...
ShareEmail, Linked In, Twitter, Facebook, Google Plus
By Benjamin R. Holt Comments are off
Post-grant review (PGR) is the least common post-issuance trial proceeding before the Patent Trial and Appeal Board (PTAB). Only 1% of...
ShareEmail, Linked In, Twitter, Facebook, Google Plus
By Nicole M. DeAbrantes Comments are off
In an effort to combat pharmaceutical patent holders, several companies are now filing petitions for post-grant review on the theory that...
ShareEmail, Linked In, Twitter, Facebook, Google Plus